Board’s research at the University of Basra college of Medicine discussed fatty acid-binding protein (liver type 1) as a marker of diabetic nephropathy. The research presented by student Mariam Muhammad Ali aims to verify the relationship between nephropathy in T2DM patients and prevalent FABP1 levels. Diabetes is the most common cause of diabetic nephropathy and is a serious public health concern worldwide. Renal impairment affects about 20-30% of people with type 2 diabetes (T2DM). In response to hypoxia caused by reduced blood flow around the capillary tube, fatty acid -binding protein1 (FABP1) is produced in nearby renal tube cells and discharged into urine. According to the increasing data, FABP1 appears to have a role in the development of chronic kidney disease The research concluded that the level of FAPB1 in plasma was significantly associated with diabetic nephropathy FABP1 could be a new biomarker for diabetic nephropathy.
